Literature DB >> 28760777

SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.

Xiaolong Zhu1, Sha Ding1, Cong Qiu1, Yanna Shi1, Lin Song1, Yueyue Wang1, Yuewen Wang1, Jinying Li1, Yiran Wang1, Yi Sun1, Lingfeng Qin1, Jun Chen1, Michael Simons1, Wang Min1, Luyang Yu2.   

Abstract

RATIONALE: The highly conserved NOTCH (neurogenic locus notch homolog protein) signaling pathway functions as a key cell-cell interaction mechanism controlling cell fate and tissue patterning, whereas its dysregulation is implicated in a variety of developmental disorders and cancers. The pivotal role of endothelial NOTCH in regulation of angiogenesis is widely appreciated; however, little is known about what controls its signal transduction. Our previous study indicated the potential role of post-translational SUMO (small ubiquitin-like modifier) modification (SUMOylation) in vascular disorders.
OBJECTIVE: The aim of this study was to investigate the role of SUMOylation in endothelial NOTCH signaling and angiogenesis. METHODS AND
RESULTS: Endothelial SENP1 (sentrin-specific protease 1) deletion, in newly generated endothelial SENP1 (the major protease of the SUMO system)-deficient mice, significantly delayed retinal vascularization by maintaining prolonged NOTCH1 signaling, as confirmed in cultured endothelial cells. An in vitro SUMOylation assay and immunoprecipitation revealed that when SENP1 associated with N1ICD (NOTCH1 intracellular domain), it functions as a deSUMOylase of N1ICD SUMOylation on conserved lysines. Immunoblot and immunoprecipitation analyses and dual-luciferase assays of natural and SUMO-conjugated/nonconjugated NOTCH1 forms demonstrated that SUMO conjugation facilitated NOTCH1 cleavage. This released N1ICD from the membrane and stabilized it for translocation to the nucleus where it functions as a cotranscriptional factor. Functionally, SENP1-mediated NOTCH1 deSUMOylation was required for NOTCH signal activation in response to DLL4 (Delta-like 4) stimulation. This in turn suppressed VEGF (vascular endothelial growth factor) receptor signaling and angiogenesis, as evidenced by immunoblotted signaling molecules and in vitro angiogenesis assays.
CONCLUSIONS: These results establish reversible NOTCH1 SUMOylation as a regulatory mechanism in coordinating endothelial angiogenic signaling; SENP1 acts as a critical intrinsic mediator of this process. These findings may apply to NOTCH-regulated biological events in nonvascular tissues and provide a novel therapeutic strategy for vascular diseases and tumors.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  NOTCH1; SENP1; SUMOylation; angiogenesis

Mesh:

Substances:

Year:  2017        PMID: 28760777      PMCID: PMC5581236          DOI: 10.1161/CIRCRESAHA.117.310696

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

Review 1.  SUMO, ubiquitin's mysterious cousin.

Authors:  S Müller; C Hoege; G Pyrowolakis; S Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 2.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

3.  Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.

Authors:  Mats Hellström; Li-Kun Phng; Jennifer J Hofmann; Elisabet Wallgard; Leigh Coultas; Per Lindblom; Jackelyn Alva; Ann-Katrin Nilsson; Linda Karlsson; Nicholas Gaiano; Keejung Yoon; Janet Rossant; M Luisa Iruela-Arispe; Mattias Kalén; Holger Gerhardt; Christer Betsholtz
Journal:  Nature       Date:  2007-01-28       Impact factor: 49.962

4.  Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs.

Authors:  Jowita Mikolajczyk; Marcin Drag; Miklós Békés; John T Cao; Ze'ev Ronai; Guy S Salvesen
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

5.  Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.

Authors:  Emman Shubbar; Jenny Vegfors; Maria Carlström; Stina Petersson; Charlotta Enerbäck
Journal:  Breast Cancer Res Treat       Date:  2011-12-22       Impact factor: 4.872

Review 6.  The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth.

Authors:  Gavin Thurston; Irene Noguera-Troise; George D Yancopoulos
Journal:  Nat Rev Cancer       Date:  2007-05       Impact factor: 60.716

7.  Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development.

Authors:  Ryosuke Tsunematsu; Keiko Nakayama; Yuichi Oike; Masaaki Nishiyama; Noriko Ishida; Shigetsugu Hatakeyama; Yasumasa Bessho; Ryoichiro Kageyama; Toshio Suda; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

8.  Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.

Authors:  Tuomas Tammela; Georgia Zarkada; Elisabet Wallgard; Aino Murtomäki; Steven Suchting; Maria Wirzenius; Marika Waltari; Mats Hellström; Tibor Schomber; Reetta Peltonen; Catarina Freitas; Antonio Duarte; Helena Isoniemi; Pirjo Laakkonen; Gerhard Christofori; Seppo Ylä-Herttuala; Masabumi Shibuya; Bronislaw Pytowski; Anne Eichmann; Christer Betsholtz; Kari Alitalo
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

Review 9.  Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis.

Authors:  Matthew T Holderfield; Christopher C W Hughes
Journal:  Circ Res       Date:  2008-03-28       Impact factor: 17.367

10.  GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs.

Authors:  Qi Zhao; Yubin Xie; Yueyuan Zheng; Shuai Jiang; Wenzhong Liu; Weiping Mu; Zexian Liu; Yong Zhao; Yu Xue; Jian Ren
Journal:  Nucleic Acids Res       Date:  2014-05-31       Impact factor: 16.971

View more
  11 in total

1.  The significance of SUMOylation of angiogenic factors in cancer progression.

Authors:  Mei Wang; Xiaodong Jiang
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

2.  Decreased OLA1 (Obg-Like ATPase-1) Expression Drives Ubiquitin-Proteasome Pathways to Downregulate Mitochondrial SOD2 (Superoxide Dismutase) in Persistent Pulmonary Hypertension of the Newborn.

Authors:  Adam Schultz; Olubunmi A Olorundami; Ru-Jeng Teng; Jason Jarzembowski; Zheng-Zheng Shi; Suresh N Kumar; Kirkwood Pritchard; Girija G Konduri; Adeleye J Afolayan
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

3.  Ubc9 Attenuates Myocardial Ischemic Injury Through Accelerating Autophagic Flux.

Authors:  Qing Xiao; Xiu-Hui Chen; Ru-Chao Jiang; Sheng-Ying Chen; Kai-Feng Chen; Xiang Zhu; Xiao-Ling Zhang; Jun-Jun Huang; Yuan Qin; Gui-Ping Zhang; Quan Yi; Jian-Dong Luo
Journal:  Front Pharmacol       Date:  2020-09-15       Impact factor: 5.810

4.  Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

Authors:  David J Clark; Saravana M Dhanasekaran; Francesca Petralia; Jianbo Pan; Xiaoyu Song; Yingwei Hu; Felipe da Veiga Leprevost; Boris Reva; Tung-Shing M Lih; Hui-Yin Chang; Weiping Ma; Chen Huang; Christopher J Ricketts; Lijun Chen; Azra Krek; Yize Li; Dmitry Rykunov; Qing Kay Li; Lin S Chen; Umut Ozbek; Suhas Vasaikar; Yige Wu; Seungyeul Yoo; Shrabanti Chowdhury; Matthew A Wyczalkowski; Jiayi Ji; Michael Schnaubelt; Andy Kong; Sunantha Sethuraman; Dmitry M Avtonomov; Minghui Ao; Antonio Colaprico; Song Cao; Kyung-Cho Cho; Selim Kalayci; Shiyong Ma; Wenke Liu; Kelly Ruggles; Anna Calinawan; Zeynep H Gümüş; Daniel Geiszler; Emily Kawaler; Guo Ci Teo; Bo Wen; Yuping Zhang; Sarah Keegan; Kai Li; Feng Chen; Nathan Edwards; Phillip M Pierorazio; Xi Steven Chen; Christian P Pavlovich; A Ari Hakimi; Gabriel Brominski; James J Hsieh; Andrzej Antczak; Tatiana Omelchenko; Jan Lubinski; Maciej Wiznerowicz; W Marston Linehan; Christopher R Kinsinger; Mathangi Thiagarajan; Emily S Boja; Mehdi Mesri; Tara Hiltke; Ana I Robles; Henry Rodriguez; Jiang Qian; David Fenyö; Bing Zhang; Li Ding; Eric Schadt; Arul M Chinnaiyan; Zhen Zhang; Gilbert S Omenn; Marcin Cieslik; Daniel W Chan; Alexey I Nesvizhskii; Pei Wang; Hui Zhang
Journal:  Cell       Date:  2019-10-31       Impact factor: 41.582

5.  SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis.

Authors:  Huanjiao Jenny Zhou; Zhe Xu; Zongren Wang; Haifeng Zhang; Zhen W Zhuang; Michael Simons; Wang Min
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

6.  A Unique SUMO-Interacting Motif of Trx2 Is Critical for Its Mitochondrial Presequence Processing and Anti-oxidant Activity.

Authors:  Chaofei Chen; Kang Wang; Haifeng Zhang; Huanjiao Jenny Zhou; Yuxin Chen; Wang Min
Journal:  Front Physiol       Date:  2019-08-27       Impact factor: 4.566

Review 7.  Decoding the PTM-switchboard of Notch.

Authors:  Daniel Antfolk; Christian Antila; Kati Kemppainen; Sebastian K-J Landor; Cecilia Sahlgren
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-07-11       Impact factor: 4.739

8.  NOTCH3 signaling is essential for NF-κB activation in TLR-activated macrophages.

Authors:  Susana López-López; Eva María Monsalve; María José Romero de Ávila; Julia González-Gómez; Natalia Hernández de León; Francisco Ruiz-Marcos; Victoriano Baladrón; María Luisa Nueda; María Jesús García-León; Isabella Screpanti; María Pía Felli; Jorge Laborda; José Javier García-Ramírez; María José M Díaz-Guerra
Journal:  Sci Rep       Date:  2020-09-09       Impact factor: 4.379

9.  SENP3 regulates high glucose-induced endothelial dysfunction via ROS dependent signaling.

Authors:  Fuheng Chen; Dongdong Ma; Aizhong Li
Journal:  Diab Vasc Dis Res       Date:  2020 Nov-Dec       Impact factor: 3.291

Review 10.  SUMOylation in development and neurodegeneration.

Authors:  Tak-Yu Yau; Oscar Molina; Albert J Courey
Journal:  Development       Date:  2020-03-18       Impact factor: 6.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.